Aramark
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-75.0% vs price
Base Case (Median)
-55.2% vs price
Bull Case (75th pct.)
-39.7% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $-3.94 | -106.4% | High (40%) |
| PE Comparable | $27.67 | -55.2% | Medium (25%) |
| Growth Trajectory DCF | $39.04 | -36.8% | Medium (20%) |
| Graham Number | $19.59 | -68.3% | High (80%) |
| EV/EBITDA | $47.32 | -23.4% | Medium (20%) |
| EV/FCF | $35.46 | -42.6% | Medium (20%) |
| Earnings Power Value | $11.30 | -81.7% | High (70%) |
Based on 7 out of 8 methods, ARMK appears overvalued at the current price of $61.80. The base case fair value of $27.67 implies 55.2% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.